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Is Computed Tomography of the Head Useful Before Lumbar Puncture?
Sir-Tunkel et al. [1] should be congratulated for their Practice Guidelines for the Management of Bacterial Meningitis, which admirably tackle several controversial aspects of the management of this disease. However, one controversial strategy may merit further debate: the role of CT of the head before lumbar puncture. The practice guidelines and standard community practice make a major assumption that I believe is not supported by peer-reviewed data. The overriding assumption is that head CT can reliably predict who will and who will not experience brain herniation after lumbar puncture. In fact, there is considerable published data indicating just the opposite.
In a recent prospective investigation by Hasbun et al. [2] , none of the 7 patients with mild-to-moderate mass effect on head CT scan experienced brain herniation after undergoing lumbar puncture. Furthermore, 4 patients had mass effect on head CTs that caused their treating clinicians not to perform lumbar punctures. Two of those 4 patients experienced brain herniation despite not undergoing lumbar puncture. The conclusion? Having mass effect on a CT did not predict postlumbar puncture herniation, and not performing a lumbar puncture for patients with mass effect did not prevent herniation.
The results of numerous other studies are concordant. For example, 10 of 75 patients with Streptococcus pneumonia meningitis experienced brain herniation after lumbar puncture, and only 2 of those patients had abnormal CT findings before lumbar puncture [3] . Furthermore, 26 of the 65 patients who did not experience brain herniation after lumbar puncture had had abnormal CT findings [3] . In a different study [4] , 36 patients underwent lumbar puncture despite having mass effect on the CT, and only 1 patient experienced brain herniation after lumbar puncture. In a review of the literature, a total of 4 (1.3%) of 296 patients with focal mass effect were found to have experienced brain herniation after lumbar puncture [4] . A prospective description of 38 patients with focal mass lesions on CT who underwent lumbar puncture found that only 1 patient (2.6%) experienced brain herniation after lumber puncture [5] . Similarly, in older studies, of 495 patients with brain tumors who underwent lumbar puncture, only 1 (0.2%) developed a complication from the lumbar puncture [5] . The conclusion from these studies, including several performed prospectively, is that CT cannot reliably be used to predict who will or will not experience brain herniation after lumbar puncture.
Why do we persist in using the CT scan for this purpose, despite the lack of supportive data? I am as guilty of this practice as anyone else, and the reason is simple: I am a chicken. No one wants to get sued, and as long as it is felt that performing the CT is the standard of care, lawyers will force us to perform this test, despite the fact that the currently available medical evidence indicates that the test is not useful in these situations. We desperately need a large, definitive, prospective evaluation of the utility of head CT to predict postlumbar puncture herniation. Failing this, perhaps it is time for an open dialogue in the infectious diseases community on whether we should continue to promote use of CT before lumbar puncture as the standard of care for any patients.
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Potential conflicts of interest. B.S.: no conflicts. [2] fully addressed the remaining 64% of the trial population [3] , which consisted of patients with Neisseria meningitidis meningitis ( ), menn p 97 ingitis due to "other bacteria" ( ), n p 29 and negative culture results ( ). The n p 67 overall results of the trial were based on a total of 301 patients with multiple causes of bacterial meningitis, and not on the subgroup of patients with Streptococcus pneumoniae meningitis alone [3] .
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The de Gans and van de Beek study [3] , like most clinical trials, was not powered to analyze all subgroups of interest. Therefore, the absence of a significant benefit in any subgroup, such as with the subgroup of patients with N. meningitidis infection, is plagued by false-negative results. On the other hand, multiple subgroup analyses create a considerable risk for false-positive results, which could potentially be the case for the S. pneumoniae subset analysis. In fact, if adjustment for multiplicity was made using the Bonferroni method, not a single result from any of the subgroup analyses (including analysis of the S. pneumoniae subset) would have statistical significance. According to the Consolidating Standards of Reporting Trials (CONSORT) Guidelines [4] , formal evaluations of interaction should be reported for each subgroup. The BreslowDay test for interaction yielded P values of .20 for "death" and .37 for "unfavorable outcome," indicating no significant effect of S. pneumoniae infection status on the magnitude of the treatment effect. Thus, the lack of significant interaction in de Gans and van de Beek study [3] supports neither the conclusion that the subgroups are heterogeneous nor the recommendation for the use of dexamethasone for pneumococcal meningitis only.
Alternatively, the benefits of steroid therapy for bacterial meningitis may depend on the baseline risk of death, as seen in sepsis trials [5] . The larger effect seen in the pneumococcal meningitis subgroup, which had substantially higher mortality in the control group (34%), compared to that in the meningococcal subgroup (2%), supports this concept. In addition, de Gans and van de Beek study [3] reported that steroid therapy had a larger beneficial effect for patients with moderate-to-severe disease. Nonetheless, dexamethasone therapy should not be delayed while the severity of illness is assessed, because its beneficial effects would be very unlikely to occur if administered after the initiation of antimicrobial therapy. Moreover, recently published studies suggest that steroids are beneficial for septic shock independent of the microbial etiology [6, 7] . Of note, the IDSA guidelines recognize the benefit of steroid treatment for meningitis caused by microorganisms other than gram-positive diplococci, such as Haemophilus influenza type b in children [1] .
In conclusion, (1) the absence of a biological explanation for a beneficial effect of steroid therapy on infections due to gram-positive organisms exclusively, (2) the established benefit of steroid therapy on meningitis due to gram-negative organisms (e.g., H. influenza type b), (3) the absence of a significant effect of S. pneumoniae on the magnitude of the steroid effect in the de Gans and van de Beek study [3] , (4) the recent finding that the baseline risk of death affects the extent of the treatment effect from anti-inflammatory agents, and (5) the evidence from septic shock studies that the benefit of steroid therapy is independent of the infectious agent all do not support the IDSA guidelines' recommendations for the use of dexamethasone in adults with pneumococcal meningitis only.
On the basis of the available evidence, adjunctive dexamethasone therapy should be initiated before or with receipt of the first dose of antibiotics and continued for 4 days for all adults with suspected or proven acute bacterial meningitis, regardless of microbial etiology.
